Cancer Medicine (Jun 2021)

A population study of screening history and diagnostic outcomes of women with invasive cervical cancer

  • Vicki B. Benard,
  • J. Elizabeth Jackson,
  • April Greek,
  • Virginia Senkomago,
  • Warner K. Huh,
  • Cheryll C. Thomas,
  • Lisa C. Richardson

DOI
https://doi.org/10.1002/cam4.3951
Journal volume & issue
Vol. 10, no. 12
pp. 4127 – 4137

Abstract

Read online

Abstract Background Despite advances to prevent and detect cervical cancer, national targets for screening have not been met in the United States. Previous studies suggested that approximately half of women who developed cervical cancer were not adequately screened. This study aimed to provide an updated examination of women's screening and diagnostic practices five years prior to an invasive cervical cancer diagnosis. Methods The study included women age 21 years and older diagnosed with invasive cervical cancer in 2013–2016 from three population‐based state cancer registries in the United States. Medical records abstraction identified screening history and diagnostic follow‐up. A mailed survey provided sociodemographic data. Screening was a Pap or human papillomavirus (HPV) test between 6 months and 5 years before diagnosis. Adequate follow‐up was defined per management guidelines. Results Of the 376 women, 60% (n = 228) had not been screened. Among women who received an abnormal screening result (n = 122), 67% (n = 82) had adequate follow‐up. Predictors of: (a) being screened were younger age, having a higher income, and having insurance; (b) adequate follow‐up were having a higher income, and (c) stage 1 cervical cancer were being screened and younger age. Conclusion Unlike other cancer patterns of care studies, this study uses data obtained from medical records supplemented with self‐report information to understand a woman's path to diagnosis, her follow‐up care, and the stage of her cervical cancer diagnosis. This study provides findings that could be used to reach more unscreened or under screened women and to continue lowering cervical cancer incidence in the United States.

Keywords